journal article·2015-01-14

Poly(aspartic acid)-based Degradable Assemblies for Highly Efficient Gene Delivery

Jing-Jun Nie, Xue-Bo Dou, Hao Hu, Bingran Yu, Da-Fu Chen, Ren-Xian Wang, Fu-Jian Xu

Publisher page

Abstract

Due to its good properties such as low cytotoxicity, degradability, and biocompatibility, poly(aspartic acid) (PAsp) is a good candidate for the development of new drug delivery systems. In this work, a series of new PAsp-based degradable supramolecular assemblies were prepared for effective gene therapy via the host-guest interactions between the cyclodextrin (CD)-cored PAsp-based polycations and the pendant benzene group-containing PAsp backbones. Such supramolecular assemblies exhibited good degradability, enhanced pDNA condensation ability, and low cytotoxicity. More importantly, the gene transfection efficiencies of supramolecular assemblies were much higher than those of CD-cored PAsp-based counterparts at various N/P ratios. In addition, the effective antitumor ability of assemblies was demonstrated with a suicide gene therapy system. The present study would provide a new means to produce degradable supramolecular drug delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Chemical Resource Engineering, College of Materials Science & Engineering, Beijing University of Chemical Technology, Beijing 100029, China

Key Laboratory of Carbon Fiber and Functional Polymers (Beijing University of Chemical Technology), Ministry of Education, Beijing 100029, China

Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China

Laboratory of Bone Tissue Engineering, Beijing Research Institute of Orthopaedics and Traumatology, Beijing JiShuiTan Hospital, Beijing 100035, China

Funding

Ministry of Education of the People's Republic of China · National Natural Science Foundation of China

References (40)

Show source-provided references
1. Hunt K. K. · Science · 2002 · 297 · 41510.1126/science.297.5580.415 ↗
2. De Smedt S. C. · Pharm. Res. · 2000 · 17 · 11310.1023/A:1007548826495 ↗
3. Yudovin-Farber I. · Mater. Sci. Eng., C · 2007 · 27 · 59510.1016/j.msec.2006.05.044 ↗
4. Xu F. J. · Prog. Polym. Sci. · 2011 · 36 · 109910.1016/j.progpolymsci.2010.11.005 ↗
5. Zauner W. · Adv. Drug Delivery Rev. · 1998 · 30 · 9710.1016/S0169-409X(97)00110-5 ↗
6. Uchida H. · J. Am. Chem. Soc. · 2011 · 133 · 1552410.1021/ja204466y ↗
7. Zhu Y. · ACS Appl. Mater. Interfaces · 2013 · 5 · 184010.1021/am400022q ↗
8. Kukowska-Latallo J. F. · Proc. Natl. Acad. Sci. U. S. A. · 1996 · 93 · 489710.1073/pnas.93.10.4897 ↗
9. Azzam T. · Macromolecules · 2002 · 35 · 994710.1021/ma0209592 ↗
10. Yang C. · Biomaterials · 2007 · 28 · 324510.1016/j.biomaterials.2007.03.033 ↗
11. Davis M. E. · Nat. Rev. Drug Discovery · 2004 · 3 · 102310.1038/nrd1576 ↗
12. Lee H. J. · Biomacromolecules · 2011 · 12 · 268610.1021/bm200483t ↗
13. Suma T. · ACS Nano · 2012 · 6 · 669310.1021/nn301164a ↗
14. Gao H. J. · Biomacromolecules · 2013 · 14 · 46010.1021/bm301694t ↗
15. Takae S. · J. Am. Chem. Soc. · 2008 · 130 · 600110.1021/ja800336v ↗
16. Sanada Y. · J. Phys. Chem. B · 2012 · 116 · 824110.1021/jp300936d ↗
17. Park J. S. · Langmuir · 2007 · 23 · 13810.1021/la061431j ↗
18. Diezi T. A. · Mol. Pharmaceutics · 2010 · 7 · 135510.1021/mp100069p ↗
19. Dong W. F. · J. Am. Chem. Soc. · 2009 · 131 · 380410.1021/ja808419b ↗
20. Kaneko T. · Macromolecules · 2005 · 38 · 486110.1021/ma050121p ↗
21. Xu F. J. · Biomacromolecules · 2009 · 10 · 28510.1021/bm8010165 ↗
22. Xu F. J. · Bioconjugate Chem. · 2009 · 20 · 144910.1021/bc900044h ↗
23. Wang Z. H. · Biomaterials · 2012 · 33 · 187310.1016/j.biomaterials.2011.11.027 ↗
24. Mellet C. O. · Chem. Soc. Rev. · 2011 · 40 · 158610.1039/C0CS00019A ↗
25. Li W. Y. · Org. Biomol. Chem. · 2011 · 9 · 779910.1039/c1ob05886j ↗
26. Hu Y. · Biomaterials · 2013 · 34 · 541110.1016/j.biomaterials.2013.03.092 ↗
27. Zhang J. X. · ACS Nano · 2010 · 4 · 104910.1021/nn901213a ↗
28. Miyauchi M. · J. Am. Chem. Soc. · 2004 · 126 · 1141810.1021/ja046562q ↗
29. Hu Y. · Bioconjugate Chem. · 2013 · 24 · 104910.1021/bc400115e ↗
30. Dong R. J. · Chem. Commun. · 2011 · 47 · 547310.1039/C1CC10934K ↗
31. Harada A. · Chem. Soc. Rev. · 2009 · 38 · 87510.1039/b705458k ↗
32. Dou X. B. · Biomaterials · 2014 · 9 · 301510.1016/j.biomaterials.2013.12.017 ↗
33. Poché D. S. · Synth. Commun. · 1999 · 29 · 84310.1080/00397919908086042 ↗
34. Cramer F. · J. Am. Chem. Soc. · 1967 · 89 · 1410.1021/ja00977a003 ↗
35. Jones K. H. · J. Histochem. Cytochem. · 1985 · 33 · 7710.1177/33.1.2578146 ↗
36. Xu F. J. · Macromolecules · 2011 · 44 · 237110.1021/ma200160h ↗
37. Liang B. · Biomaterials · 2009 · 30 · 401410.1016/j.biomaterials.2009.04.011 ↗
38. Hu Y. · ACS Appl. Mater. Interfaces. · 2013 · 5 · 70310.1021/am302249x ↗
39. Xiang S. N. · J. Controlled Release · 2012 · 158 · 37110.1016/j.jconrel.2011.09.093 ↗
40. Kosaka H. · Cancer Gene Ther. · 2012 · 19 · 57210.1038/cgt.2012.35 ↗